Novo Nordisk reaches RE100 goal of 100% renewably-powered production facilities

The global healthcare company is now pursuing a new target of achieving zero carbon dioxide emissions from all operations and transport by 2030

Novo Nordisk has reached its RE100 ambition of using 100% renewable electricity across all of its global production facilities by 2020.

The global healthcare company is now pursuing a new target of achieving zero carbon dioxide emissions from all operations and transport by 2030, with the ultimate goal of becoming a company with zero environmental impact in the future.

It hopes to reach this through minimising consumption and turning waste into resources through more circular business practices and products.

Lars Fruergaard Jørgensen, President and CEO of Novo Nordisk, said: “More than 30 million people use our medicines and now they can do so knowing that they’re produced using renewable electricity.

“By committing to achieve zero emissions across our operations and transport by 2030 and by applying a circular mindset across our entire business, we are working towards a day when we will be able to say that Novo Nordisk is a company with zero environmental impact.”

If you enjoyed this story, you can sign up to our newsletter for future Net Zero – and if you are interested in hearing about all things energy, you can also sign up to the Energy Live News weekly email. 

Latest Podcast